Oncolys's Esophageal Cancer Virus Therapy Reaches Japan's Drug Pricing Panel
Japan's health ministry has put the pricing of Oncolys BioPharma's newly approved esophageal cancer therapy on the agenda for the Chuikyo panel that deliberates national insurance drug prices, with the company still targeting a launch within the current fiscal year even as the earnings impact stays under review.